Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressively debilitating, rare disease associated with high mortality. ATTR-CM occurs when TTR amyloid protein builds up in the myocardium along with different organs, most commonly the peripheral and the autonomic nervous systems. Managing the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschöpe, Carsten, Elsanhoury, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031576/
https://www.ncbi.nlm.nih.gov/pubmed/35456241
http://dx.doi.org/10.3390/jcm11082148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031576/
https://www.ncbi.nlm.nih.gov/pubmed/35456241
http://dx.doi.org/10.3390/jcm11082148

Ejemplares similares